LV particles were produced by polyethylenimine (PEI) (408727, Sigma-Aldrich, St. Louis, MO, USA), as previously described [69]. Briefly, for second-generation LVs, 293T packaging cells were transfected with packaging plasmid pCMvdR8.91, plasmid pMD2.G.47 encoding the vesicular stomatitis virus (VsV-g) envelope gene (http://www.addgene.org/Didier_Trono/, accessed on 2 June 2020) and the desired vector plasmid (SG, SIFLG, SIFG or S2G). The producer cells were cultured for 24, 48 and 72 h and the viral supernatants were collected and filtered through 0.45 μm filters (Nalgene, Rochester, NY, USA). The viral particles were then concentrated by ultracentrifugation in a Beckman Optima Centrifuge (Beckman Coulter, CA, USA) at 40,000 rpm for 2 h at 4 °C, and the viral pellets were resuspended in StemSpan medium (StemCell Technologies, Vancouver, Canada) for 1 h on ice, aliquoted, and immediately frozen at −80 °C.
Viral titres (transduction units [TU]/mL) were calculated using quantitative PCR. Briefly, 105 K562 cells were transduced with serially diluted amounts of LV. Genomic DNA was isolated (105 cells, equivalent to 0.6 μg of genomic DNA) (kit QiAamp DNA Mini Kit) (Qiagen) and the copy number of LVs integrated was measured using a standard curve (from 105 to 10 copies) of plasmid DNA. We used KAPA SYBR FAST Universal qPCR (KAPA Biosystems) in a Mx3005P QPCR System from Stratagene (Agilent Technologies, Santa Clara, CA, USA). The primers used for titration were ∆U3 (fw: GACGGTACAGGCCAGACAA) and PBS (rev: TGGTGCAAATGAGTTTTCCA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.